Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Case of presymptomatic aceruloplasminemia treated with deferasirox
Mayumi Tai1, Nobuo Matsuhashi, Osamu Ichii
1Department of Gastroenterology, Fukushima Rosai Hospital, Iwaki, Japan; The Third Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Abstract:
Aceruloplasminemia is an autosomal recessive disease characterized by an abnormal iron metabolism. The absence of ferroxidase activity caused by mutation of ceruloplasmin leads to iron overload in the brain, liver and other organs. We report a 35-year-old man who was diagnosed with aceruloplasminemia without neurological manifestation despite the accumulation of iron in the brain and liver. To prevent the development of neurodegenerative disorder related to iron toxicity, iron depletion therapy was performed. Iron chelator deferasirox was effective in reducing serum ferritin level and to prevent the progression of the disease.

